Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDR | P35968 | 4/20 | 0.46 |
| ▸ | PTK2 | Q05397 | 4/20 | 0.46 |
| ▸ | PLK1 | P53350 | 2/20 | 0.46 |
| ▸ | METAP2 | P50579 | 1/20 | 0.46 |
| ▸ | METAP1 | P53582 | 1/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | AKT1 | P31749 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21022945 | 0.84 | CYP19A1 (0.49) | CYP19A1MEN1KMT2AKDRPTK2 | |
| SCHEMBL172248 | 0.81 | CYP19A1 (0.61) | CYP19A1MEN1KMT2AKDRPTK2 | |
| SCHEMBL27555515 | 0.76 | KDM4E (0.50) | METAP1L3MBTL1KDM4ENPC1ALDH1A1 | |
| SCHEMBL4814275 | 0.76 | CYP19A1 (0.56) | CYP19A1MEN1KMT2AKDRPTK2 | |
| SCHEMBL21022946 | 0.75 | CYP19A1 (0.54) | CYP19A1MEN1KMT2AKDRPTK2 | |
| SCHEMBL26512203 | 0.73 | MEN1 (0.55) | CYP19A1MEN1KMT2AKDRPTK2 | |
| SCHEMBL1533926 | 0.73 | MEN1 (0.55) | CYP19A1MEN1KMT2AKDRPTK2 | |
| SCHEMBL13239249 | 0.73 | KDR (0.58) | CYP19A1MEN1KMT2AKDRPTK2 | |
| SCHEMBL1534259 | 0.72 | MEN1 (0.52) | CYP19A1MEN1KMT2AKDRPTK2 | |
| SCHEMBL1171430 | 0.71 | MEN1 (0.69) | MEN1KMT2AMETAP2METAP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11168103-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-11-09 | — | — | US | disclosed |
| US-20190153009-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190153009-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | CHRM4, CHRM1, OPRD1 | CYP19A1 1968/4885MEN1 3730/4885KMT2A 3068/4885 |
| US-11168103-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OR10J3 | CYP19A1 2979/4885MEN1 3746/4885KMT2A 2078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.